Evaluation of Antioxidant and Skin Beauty Effects of Cherry Collagen Drink
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Tainan City, Taiwan, 71710
- Chia Nan University of Pharmacy & Science
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy adults aged above 20 years old
Exclusion Criteria:
- Subject who is not willing to participate in this study.
- Patients with diseases of the skin, liver, kidney.
- Subjects who have known cosmetic, drug or food allergies, difficulty in digestive tract absorption or disorder.
- Female who is pregnant or nursing or planning to become pregnant during the course of the study.
- Received facial laser therapy, chemical peeling or UV overexposure (> 3 hr/week) in the past 4 weeks.
- Constant drug use
- Students who are currently taking courses taught by the principal investigator of this trial.
- Body weight < 50 kg.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo drink
|
consume 1 sachet per day
|
|
Experimental: Cherry collagen drink
|
consume 1 sachet per day
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of skin wrinkles
Time Frame: Change from Baseline skin wrinkles at 8 weeks
|
VISIA Complexion Analysis System was utilized to measure skin wrinkles.
Units: arbitrary units
|
Change from Baseline skin wrinkles at 8 weeks
|
|
The change of skin texture
Time Frame: Change from Baseline skin texture at 8 weeks
|
VISIA Complexion Analysis System was utilized to measure skin texture.
Units: arbitrary units
|
Change from Baseline skin texture at 8 weeks
|
|
The change of skin collagen density
Time Frame: Change from Baseline skin collagen density at 8 weeks
|
DermaLab® Series SkinLab Combo was utilized to measure skin pores.
Units: arbitrary units
|
Change from Baseline skin collagen density at 8 weeks
|
|
The change of skin elasticity
Time Frame: Change from Baseline skin elasticity at 8 weeks
|
Soft Plus was utilized to measure skin elasticity.
Units: arbitrary units
|
Change from Baseline skin elasticity at 8 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of skin L* value
Time Frame: Change from Baseline L* value at 8 weeks
|
Chroma Meter MM500 was utilized to measure skin L* value.
Units: arbitrary units, 0-100
|
Change from Baseline L* value at 8 weeks
|
|
The change of skin moisture
Time Frame: Change from Baseline skin moisture at 8 weeks
|
Corneometer® CM825 was utilized to measure skin moisture.
Units: arbitrary Corneometer® units 0-120
|
Change from Baseline skin moisture at 8 weeks
|
|
The change of skin UV spots
Time Frame: Change from Baseline skin UV spots at 8 weeks
|
VISIA Complexion Analysis System was utilized to measure skin UV spots.
Units: arbitrary units
|
Change from Baseline skin UV spots at 8 weeks
|
|
The change of skin melanin index
Time Frame: Change from Baseline skin melanin index at 8 weeks
|
Soft Plus was utilized to measure skin melanin index.
Units: arbitrary units
|
Change from Baseline skin melanin index at 8 weeks
|
|
The change of blood total antioxidant capacity (TAC)
Time Frame: Change from Baseline TAC at 8 weeks
|
Venous blood was sampled to measure concentrations of TAC
|
Change from Baseline TAC at 8 weeks
|
|
The change of skin spots
Time Frame: Change from Baseline skin spots at 8 weeks
|
VISIA Complexion Analysis System was utilized to measure skin spots.
Units: arbitrary units
|
Change from Baseline skin spots at 8 weeks
|
|
The change of skin brown spots
Time Frame: Change from Baseline skin brown spots at 8 weeks
|
VISIA Complexion Analysis System was utilized to measure skin brown spots.
Units: arbitrary units
|
Change from Baseline skin brown spots at 8 weeks
|
|
The change of SOD-RBC of blood
Time Frame: Change from Baseline SOD-RBC at 8 weeks
|
Venous blood was sampled to measure SOD-RBC
|
Change from Baseline SOD-RBC at 8 weeks
|
|
The change of t-GSH of blood
Time Frame: Change from Baseline t-GSH at 8 weeks
|
Venous blood was sampled to measure t-GSH
|
Change from Baseline t-GSH at 8 weeks
|
|
The change of GST-RBC of blood
Time Frame: Change from Baseline GST-RBC at 8 weeks
|
Venous blood was sampled to measure GST-RBC
|
Change from Baseline GST-RBC at 8 weeks
|
|
The change of desmosine of blood
Time Frame: Change from Baseline desmosine at 8 weeks
|
Venous blood was sampled to measure concentrations of desmosine
|
Change from Baseline desmosine at 8 weeks
|
|
The change of TNF-alpha of blood
Time Frame: Change from Baseline TNF-alpha at 8 weeks
|
Venous blood was sampled to measure concentrations of TNF-alpha
|
Change from Baseline TNF-alpha at 8 weeks
|
|
The change of transepidermal water loss (TEWL)
Time Frame: Change from Baseline TEWL at 8 weeks
|
Tewameter® TM300 was utilized to measure TEWL.
Units: g/hm²
|
Change from Baseline TEWL at 8 weeks
|
Other Outcome Measures
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The change of self-assessment skin condition
Time Frame: Change from Baseline skin condition at 8 weeks
|
A self-assessment questionnaire was collected to evaluate skin condition
|
Change from Baseline skin condition at 8 weeks
|
|
The change of liver function biomarkers (AST, ALT) of blood
Time Frame: Change from Baseline liver function biomarkers at 8 weeks
|
Venous blood was sampled to measure liver function biomarkers
|
Change from Baseline liver function biomarkers at 8 weeks
|
|
The change of renal function biomarkers (creatinine, BUN) of blood
Time Frame: Change from Baseline renal function biomarkers at 8 weeks
|
Venous blood was sampled to measure renal function biomarkers
|
Change from Baseline renal function biomarkers at 8 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Chia-Hua Liang, Chia Nan University of Pharmacy & Science
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 22-010-B
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.